Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women

Mia M. Gaudet, Stephen Chanock, Jolanta Lissowska, Sonja I. Berndt, Xiaohong Yang, Beata Peplonska, Louise A. Brinton, Robert Welch, Meredith Yeager, Alicja Bardin-Mikolajczak, Mark E. Sherman, Thomas R. Sutter, Montserrat Garcia-Closas

Research output: Contribution to journalArticle

Abstract

Four single nucleotide polymorphisms (SNPs) in CYP1B1 (Ex2+143 C>G, Ex2+356 G>T, Ex3+251 G>C, Ex3+315 A>G) cause amino acid changes (R48G, A119S, L432V and N453S, respectively) and are associated with increased formation of catechol estrogens; however, epidemiologic evidence only weakly supports an association between these variants and breast cancer risk. Because genetic variability conferring increased susceptibility could exist beyond these putative functional variants, we comprehensively examined the common genetic variability within CYP1B1. A total of eight haplotype-tagging (ht)SNPs (including Ex3+315 A>G), in addition to two putatively functional SNPs (Ex2+143 C>G and Ex3+251 G>C), were selected and genotyped in a large case-control study of Polish women (1995 cases and 2296 controls). Haplotypes were estimated using the expectation-maximization algorithm, and overall differences in the haplotype distribution between cases and controls were assessed using a global score test. We also evaluated levels of tumor CYP1B1 protein expression in a subset of 841 cases by immunohistochemistry, and their association with genetic variants. In the Polish population, we observed two linkage disequilibrium (LD)-defined blocks. Neither haplotypes (global P-value of 0.99 and 0.67 for each block of LD, respectively), nor individual SNPs (including three putatively functional SNPs) were associated with breast cancer risk. CYP1B1 was expressed in most tumor tissues (98%), and the level of expression was not related to the studied genetic variants. We found little evidence for modification of the estimated effect of haplotypes or individual SNPs by age, family history of breast cancer, or tumor hormone receptor status. The present study provides strong evidence against the existence of a substantial overall association between common genetic variation in CYP1B1 and breast cancer risk.

Original languageEnglish (US)
Pages (from-to)547-553
Number of pages7
JournalPharmacogenetics and Genomics
Volume16
Issue number8
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Cytochrome P-450 Enzyme System
Single Nucleotide Polymorphism
Haplotypes
Breast Neoplasms
Linkage Disequilibrium
Catechol Estrogens
Case-Control Studies
Neoplasms
Immunohistochemistry
Hormones
Amino Acids
Population
Proteins

Keywords

  • Breast cancer
  • CYP1B1
  • Family history
  • Haplotypes
  • P450s

ASJC Scopus subject areas

  • Genetics
  • Pharmacology

Cite this

Gaudet, M. M., Chanock, S., Lissowska, J., Berndt, S. I., Yang, X., Peplonska, B., ... Garcia-Closas, M. (2006). Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenetics and Genomics, 16(8), 547-553. https://doi.org/10.1097/01.fpc.0000215067.29342.6f

Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. / Gaudet, Mia M.; Chanock, Stephen; Lissowska, Jolanta; Berndt, Sonja I.; Yang, Xiaohong; Peplonska, Beata; Brinton, Louise A.; Welch, Robert; Yeager, Meredith; Bardin-Mikolajczak, Alicja; Sherman, Mark E.; Sutter, Thomas R.; Garcia-Closas, Montserrat.

In: Pharmacogenetics and Genomics, Vol. 16, No. 8, 08.2006, p. 547-553.

Research output: Contribution to journalArticle

Gaudet, MM, Chanock, S, Lissowska, J, Berndt, SI, Yang, X, Peplonska, B, Brinton, LA, Welch, R, Yeager, M, Bardin-Mikolajczak, A, Sherman, ME, Sutter, TR & Garcia-Closas, M 2006, 'Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women', Pharmacogenetics and Genomics, vol. 16, no. 8, pp. 547-553. https://doi.org/10.1097/01.fpc.0000215067.29342.6f
Gaudet, Mia M. ; Chanock, Stephen ; Lissowska, Jolanta ; Berndt, Sonja I. ; Yang, Xiaohong ; Peplonska, Beata ; Brinton, Louise A. ; Welch, Robert ; Yeager, Meredith ; Bardin-Mikolajczak, Alicja ; Sherman, Mark E. ; Sutter, Thomas R. ; Garcia-Closas, Montserrat. / Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. In: Pharmacogenetics and Genomics. 2006 ; Vol. 16, No. 8. pp. 547-553.
@article{62fcd63689004b458509ac449468625a,
title = "Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women",
abstract = "Four single nucleotide polymorphisms (SNPs) in CYP1B1 (Ex2+143 C>G, Ex2+356 G>T, Ex3+251 G>C, Ex3+315 A>G) cause amino acid changes (R48G, A119S, L432V and N453S, respectively) and are associated with increased formation of catechol estrogens; however, epidemiologic evidence only weakly supports an association between these variants and breast cancer risk. Because genetic variability conferring increased susceptibility could exist beyond these putative functional variants, we comprehensively examined the common genetic variability within CYP1B1. A total of eight haplotype-tagging (ht)SNPs (including Ex3+315 A>G), in addition to two putatively functional SNPs (Ex2+143 C>G and Ex3+251 G>C), were selected and genotyped in a large case-control study of Polish women (1995 cases and 2296 controls). Haplotypes were estimated using the expectation-maximization algorithm, and overall differences in the haplotype distribution between cases and controls were assessed using a global score test. We also evaluated levels of tumor CYP1B1 protein expression in a subset of 841 cases by immunohistochemistry, and their association with genetic variants. In the Polish population, we observed two linkage disequilibrium (LD)-defined blocks. Neither haplotypes (global P-value of 0.99 and 0.67 for each block of LD, respectively), nor individual SNPs (including three putatively functional SNPs) were associated with breast cancer risk. CYP1B1 was expressed in most tumor tissues (98{\%}), and the level of expression was not related to the studied genetic variants. We found little evidence for modification of the estimated effect of haplotypes or individual SNPs by age, family history of breast cancer, or tumor hormone receptor status. The present study provides strong evidence against the existence of a substantial overall association between common genetic variation in CYP1B1 and breast cancer risk.",
keywords = "Breast cancer, CYP1B1, Family history, Haplotypes, P450s",
author = "Gaudet, {Mia M.} and Stephen Chanock and Jolanta Lissowska and Berndt, {Sonja I.} and Xiaohong Yang and Beata Peplonska and Brinton, {Louise A.} and Robert Welch and Meredith Yeager and Alicja Bardin-Mikolajczak and Sherman, {Mark E.} and Sutter, {Thomas R.} and Montserrat Garcia-Closas",
year = "2006",
month = "8",
doi = "10.1097/01.fpc.0000215067.29342.6f",
language = "English (US)",
volume = "16",
pages = "547--553",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women

AU - Gaudet, Mia M.

AU - Chanock, Stephen

AU - Lissowska, Jolanta

AU - Berndt, Sonja I.

AU - Yang, Xiaohong

AU - Peplonska, Beata

AU - Brinton, Louise A.

AU - Welch, Robert

AU - Yeager, Meredith

AU - Bardin-Mikolajczak, Alicja

AU - Sherman, Mark E.

AU - Sutter, Thomas R.

AU - Garcia-Closas, Montserrat

PY - 2006/8

Y1 - 2006/8

N2 - Four single nucleotide polymorphisms (SNPs) in CYP1B1 (Ex2+143 C>G, Ex2+356 G>T, Ex3+251 G>C, Ex3+315 A>G) cause amino acid changes (R48G, A119S, L432V and N453S, respectively) and are associated with increased formation of catechol estrogens; however, epidemiologic evidence only weakly supports an association between these variants and breast cancer risk. Because genetic variability conferring increased susceptibility could exist beyond these putative functional variants, we comprehensively examined the common genetic variability within CYP1B1. A total of eight haplotype-tagging (ht)SNPs (including Ex3+315 A>G), in addition to two putatively functional SNPs (Ex2+143 C>G and Ex3+251 G>C), were selected and genotyped in a large case-control study of Polish women (1995 cases and 2296 controls). Haplotypes were estimated using the expectation-maximization algorithm, and overall differences in the haplotype distribution between cases and controls were assessed using a global score test. We also evaluated levels of tumor CYP1B1 protein expression in a subset of 841 cases by immunohistochemistry, and their association with genetic variants. In the Polish population, we observed two linkage disequilibrium (LD)-defined blocks. Neither haplotypes (global P-value of 0.99 and 0.67 for each block of LD, respectively), nor individual SNPs (including three putatively functional SNPs) were associated with breast cancer risk. CYP1B1 was expressed in most tumor tissues (98%), and the level of expression was not related to the studied genetic variants. We found little evidence for modification of the estimated effect of haplotypes or individual SNPs by age, family history of breast cancer, or tumor hormone receptor status. The present study provides strong evidence against the existence of a substantial overall association between common genetic variation in CYP1B1 and breast cancer risk.

AB - Four single nucleotide polymorphisms (SNPs) in CYP1B1 (Ex2+143 C>G, Ex2+356 G>T, Ex3+251 G>C, Ex3+315 A>G) cause amino acid changes (R48G, A119S, L432V and N453S, respectively) and are associated with increased formation of catechol estrogens; however, epidemiologic evidence only weakly supports an association between these variants and breast cancer risk. Because genetic variability conferring increased susceptibility could exist beyond these putative functional variants, we comprehensively examined the common genetic variability within CYP1B1. A total of eight haplotype-tagging (ht)SNPs (including Ex3+315 A>G), in addition to two putatively functional SNPs (Ex2+143 C>G and Ex3+251 G>C), were selected and genotyped in a large case-control study of Polish women (1995 cases and 2296 controls). Haplotypes were estimated using the expectation-maximization algorithm, and overall differences in the haplotype distribution between cases and controls were assessed using a global score test. We also evaluated levels of tumor CYP1B1 protein expression in a subset of 841 cases by immunohistochemistry, and their association with genetic variants. In the Polish population, we observed two linkage disequilibrium (LD)-defined blocks. Neither haplotypes (global P-value of 0.99 and 0.67 for each block of LD, respectively), nor individual SNPs (including three putatively functional SNPs) were associated with breast cancer risk. CYP1B1 was expressed in most tumor tissues (98%), and the level of expression was not related to the studied genetic variants. We found little evidence for modification of the estimated effect of haplotypes or individual SNPs by age, family history of breast cancer, or tumor hormone receptor status. The present study provides strong evidence against the existence of a substantial overall association between common genetic variation in CYP1B1 and breast cancer risk.

KW - Breast cancer

KW - CYP1B1

KW - Family history

KW - Haplotypes

KW - P450s

UR - http://www.scopus.com/inward/record.url?scp=33746255666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746255666&partnerID=8YFLogxK

U2 - 10.1097/01.fpc.0000215067.29342.6f

DO - 10.1097/01.fpc.0000215067.29342.6f

M3 - Article

C2 - 16847423

AN - SCOPUS:33746255666

VL - 16

SP - 547

EP - 553

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

SN - 1744-6872

IS - 8

ER -